Mark Levin Jounce Therapeutics, Inc

As of November 16, 2021


Mark Levin Net Worth

  • Net worth is estimated to be at least $2.13B
  • Owns at least 1,432,638 units of Jounce Therapeutics, Inc stock
  • Sold an estimated value of $37.59M in the last 4 years at Jounce Therapeutics, Inc

Mark Levin Trading

  • Largest sale of shares was 1,450,000 units , worth over $17.04M on March 3, 2021
  • In total has made about 10 transactions over 4 years
  • Usually trades in November, with the busiest year in 2021

Third Rock Ventures III LP, Third Rock Ventures GP III LP, TRV GP III LLC, KEVIN STARR, ROBERT TEPPER, MARK LEVIN

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Mark Levin Mailing Address

  • Mailing address is 29 Newbury Street 3rd Floor Boston MA 02116 MA

Jounce Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Compensation
Total
Richard Murray, Ph.D., 2020 $565,100 $310,810 $491,316 $627,312 $8,946 $2,003,484
Richard Murray, Ph.D., 2019 $540,800 $295,500 $275,044 $348,665 $8,796 $1,468,805
Hugh M. Cole 2020 $420,000 $212,520 $196,500 $250,908 $8,808 $1,088,736
Hugh M. Cole 2019 $401,700 $153,700 $97,900 $124,115 $5,709 $783,124
Kim C. Drapkin 2020 $398,400 $175,300 $174,885 $223,308 $8,688 $980,581
Kim C. Drapkin 2019 $381,200 $145,800 $97,900 $124,115 $8,796 $757,811
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1640455/000164045521000078/jnce042621def14a.htm

Jounce Therapeutics, Inc Insider Trading

  • The most recent transaction was 1,900,000 units sold on November 16, 2021 by Third Rock Ventures Iii Lp, Third Rock Ventures GP Iii Lp, Trv GP Iii Llc, Kevin Starr, Robert Tepper and Mark Levin worth over $15.92M
  • In the last 4 years, insiders at Jounce Therapeutics, Inc sold an estimated value of $41.96M and bought an estimated value of $10.7M
  • The most active traders are Elizabeth Trehu, Chief Medical Officer,  Kimberlee C Drapkin, CFO and Treasurer,  and Cary Pfeffer, Director
  • Insider trading is most common in June, with the busiest year in 2021

Jounce Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1